Jennison Associates LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Jennison Associates LLC

  • $155 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 02, 2022
BUY
$83.14 - $145.99 $558,534 - $980,760
6,718 New
6,718 $979,000
Q4 2020

Feb 05, 2021
SELL
$65.07 - $98.24 $618,360 - $933,574
-9,503 Closed
0 $0
Q3 2020

Nov 04, 2020
BUY
$59.04 - $77.95 $10,332 - $13,641
175 Added 1.88%
9,503 $618,000
Q2 2020

Aug 06, 2020
BUY
$29.01 - $74.23 $270,605 - $692,417
9,328 New
9,328 $682,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email